Revolutionize the treatment landscape for orphan diseases by uncovering the potential of repurposing medications to improve patient outcomes.
The Coastal Program for Rare Inflammatory Diseases at Vancouver Coastal Health, led by Dr. Luke Chen, is building a collaborative network to accelerate treatments for patients with rare and orphan diseases through innovative, cost-effective drug repurposing strategies.
In partnership with the U.S.-based Every Cure organization, the program utilizes artificial intelligence and computational pharmacophenomics to identify existing medications that may treat rare diseases, reducing time and cost compared to traditional drug development.
By leveraging AI and collaboration, we can dramatically improve treatment options for rare diseases.
Author's summary: Repurposing medications can revolutionize rare disease treatment.